Rifamate (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Rifamate drug offered from sanofi-aventis U.S. LLC. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | rifampin and isoniazid |
SUBSTANCE NAME: | RIFAMPIN; ISONIAZID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1975-07-11 |
END MARKETING DATE: | 0000-00-00 |
Rifamate HUMAN PRESCRIPTION DRUG Details:
Item Description | Rifamate from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300; 150(mg/1; mg/1) |
START MARKETING DATE: | 1975-07-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0068-0509_414a7294-4fe1-442b-bf2b-5825d83991d2 |
PRODUCT NDC: | 0068-0509 |
APPLICATION NUMBER: | ANDA061884 |
Other RIFAMPIN; ISONIAZID Pharmaceutical Manufacturers / Labelers: